Rhenman & Partners Asset Management AB as of Dec. 31, 2018
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 89 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | 3.6 | $32M | 126k | 249.12 | |
| Cigna Corp (CI) | 3.5 | $30M | 160k | 189.92 | |
| Medtronic (MDT) | 3.1 | $27M | 300k | 90.96 | |
| CVS Caremark Corporation (CVS) | 3.1 | $27M | 409k | 65.52 | |
| Becton, Dickinson and (BDX) | 3.0 | $26M | 115k | 225.32 | |
| Humana (HUM) | 2.7 | $24M | 82k | 286.48 | |
| Alexion Pharmaceuticals | 2.6 | $22M | 230k | 97.36 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.5 | $22M | 132k | 165.71 | |
| Abiomed | 2.4 | $21M | 65k | 325.03 | |
| Anthem (ELV) | 2.4 | $21M | 79k | 262.64 | |
| Jazz Pharmaceuticals (JAZZ) | 2.4 | $21M | 166k | 123.96 | |
| Bristol Myers Squibb (BMY) | 2.2 | $19M | 370k | 51.98 | |
| Abbott Laboratories (ABT) | 2.2 | $19M | 265k | 72.33 | |
| Exelixis (EXEL) | 2.2 | $19M | 959k | 19.67 | |
| Horizon Pharma | 2.1 | $19M | 946k | 19.54 | |
| Novocure Ltd ord (NVCR) | 2.1 | $18M | 545k | 33.48 | |
| Biogen Idec (BIIB) | 2.1 | $18M | 60k | 300.92 | |
| Incyte Corporation (INCY) | 1.9 | $17M | 266k | 63.59 | |
| Nektar Therapeutics (NKTR) | 1.9 | $17M | 515k | 32.87 | |
| Esperion Therapeutics (ESPR) | 1.9 | $16M | 354k | 46.00 | |
| Diplomat Pharmacy | 1.9 | $16M | 1.2M | 13.46 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $15M | 177k | 85.15 | |
| Abbvie (ABBV) | 1.7 | $15M | 162k | 92.19 | |
| Arena Pharmaceuticals | 1.7 | $15M | 372k | 38.95 | |
| Eli Lilly & Co. (LLY) | 1.6 | $14M | 124k | 115.72 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $14M | 201k | 71.41 | |
| Fibrogen (FGEN) | 1.6 | $14M | 302k | 46.28 | |
| Celgene Corporation | 1.6 | $14M | 216k | 64.09 | |
| Centene Corporation (CNC) | 1.6 | $14M | 120k | 115.30 | |
| Seattle Genetics | 1.6 | $14M | 242k | 56.66 | |
| Glaukos (GKOS) | 1.5 | $14M | 241k | 56.17 | |
| Boston Scientific Corporation (BSX) | 1.5 | $13M | 378k | 35.34 | |
| Allergan | 1.5 | $13M | 99k | 133.66 | |
| Sage Therapeutics (SAGE) | 1.5 | $13M | 137k | 95.79 | |
| Sangamo Biosciences (SGMO) | 1.4 | $13M | 1.1M | 11.48 | |
| Gilead Sciences (GILD) | 1.4 | $12M | 188k | 62.55 | |
| Bluebird Bio (BLUE) | 1.3 | $12M | 118k | 99.20 | |
| Livanova Plc Ord (LIVN) | 1.3 | $11M | 121k | 91.47 | |
| Iovance Biotherapeutics (IOVA) | 1.2 | $11M | 1.2M | 8.85 | |
| Edwards Lifesciences (EW) | 1.2 | $10M | 67k | 153.17 | |
| Aerie Pharmaceuticals | 1.2 | $10M | 280k | 36.10 | |
| Array BioPharma | 1.1 | $9.9M | 697k | 14.25 | |
| Walgreen Boots Alliance (WBA) | 1.1 | $9.9M | 145k | 68.33 | |
| Myokardia | 1.1 | $9.3M | 189k | 48.86 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $8.1M | 112k | 72.91 | |
| Xencor (XNCR) | 0.9 | $7.9M | 219k | 36.16 | |
| AmerisourceBergen (COR) | 0.9 | $7.6M | 102k | 74.40 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $7.5M | 660k | 11.39 | |
| Macrogenics (MGNX) | 0.8 | $6.9M | 542k | 12.70 | |
| Immunomedics | 0.8 | $6.9M | 480k | 14.27 | |
| Thermo Fisher Scientific (TMO) | 0.8 | $6.7M | 30k | 223.80 | |
| Regeneron Pharmaceuticals (REGN) | 0.7 | $6.4M | 17k | 373.53 | |
| Omnicell (OMCL) | 0.7 | $6.1M | 100k | 61.24 | |
| Agios Pharmaceuticals (AGIO) | 0.7 | $5.9M | 127k | 46.11 | |
| Flexion Therapeutics | 0.7 | $5.7M | 507k | 11.32 | |
| Rigel Pharmaceuticals (RIGL) | 0.6 | $5.2M | 2.3M | 2.30 | |
| Alkermes (ALKS) | 0.6 | $5.1M | 174k | 29.51 | |
| Portola Pharmaceuticals | 0.5 | $4.7M | 242k | 19.52 | |
| Abeona Therapeutics | 0.5 | $4.6M | 649k | 7.14 | |
| Mednax (MD) | 0.5 | $4.1M | 125k | 33.00 | |
| Viewray (VRAYQ) | 0.5 | $4.0M | 664k | 6.07 | |
| Revance Therapeutics (RVNC) | 0.4 | $3.9M | 193k | 20.13 | |
| Mirati Therapeutics | 0.4 | $3.6M | 85k | 42.42 | |
| Spark Therapeutics | 0.4 | $3.5M | 88k | 39.14 | |
| G1 Therapeutics (GTHX) | 0.4 | $3.3M | 173k | 19.15 | |
| Coherus Biosciences (CHRS) | 0.3 | $2.9M | 321k | 9.05 | |
| Medicines Company | 0.3 | $2.6M | 135k | 19.14 | |
| Laboratory Corp. of America Holdings (LH) | 0.2 | $1.4M | 11k | 126.36 | |
| Amarin Corporation (AMRN) | 0.2 | $1.4M | 100k | 13.61 | |
| Adamas Pharmaceuticals | 0.2 | $1.4M | 160k | 8.54 | |
| Loxo Oncology | 0.2 | $1.4M | 10k | 140.10 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $798k | 300k | 2.66 | |
| Achillion Pharmaceuticals | 0.1 | $641k | 403k | 1.59 | |
| Chimerix (CMRX) | 0.1 | $581k | 226k | 2.57 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $417k | 6.1k | 68.24 | |
| Chevron Corporation (CVX) | 0.1 | $406k | 3.7k | 108.76 | |
| Walt Disney Company (DIS) | 0.0 | $382k | 3.5k | 109.68 | |
| Qualcomm (QCOM) | 0.0 | $369k | 6.5k | 56.98 | |
| Adverum Biotechnologies | 0.0 | $377k | 120k | 3.15 | |
| Microsoft Corporation (MSFT) | 0.0 | $293k | 2.9k | 101.49 | |
| JPMorgan Chase & Co. (JPM) | 0.0 | $268k | 2.7k | 97.56 | |
| Pfizer (PFE) | 0.0 | $219k | 5.0k | 43.72 | |
| Wells Fargo & Company (WFC) | 0.0 | $270k | 5.9k | 46.09 | |
| Halliburton Company (HAL) | 0.0 | $245k | 9.2k | 26.57 | |
| International Business Machines (IBM) | 0.0 | $280k | 2.5k | 113.77 | |
| Ford Motor Company (F) | 0.0 | $248k | 32k | 7.65 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $249k | 3.8k | 65.73 | |
| Janus Henderson Group Plc Ord (JHG) | 0.0 | $245k | 12k | 20.71 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $158k | 377k | 0.42 |
